Aktiesnakken — August 2012
-
ja sukker. der sker da noget i biotek idag
-
Hård aftale. Hard money. Hard life
-
Jeg har et depot hvor jeg har 183% profit på genmab. At man stadig er out of the money siger vist alt
-
duobody aftaler
-
@ sukker og andre gen nørder.
-
Janssen skriver de vil starte several phase III studies? hvilke indikationer kan Dara allerede gå i phase III ?
-
udover MM monotherapi?=
-
Haha i har glemt arzerra
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind